Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares
2026-05-15 18:50:53 ET
Omega Fund Management cut its stake in Kestra Medical Technologies (NASDAQ:KMTS) , selling 351,442 shares in the first quarter for an estimated $8.28 million based on quarterly average pricing, according to a May 15, 2026, SEC filing.
According to an SEC filing published May 15, 2026, Omega Fund Management decreased its position in Kestra Medical Technologies, Ltd. by 351,442 shares during the first quarter. The estimated transaction value was $8.28 million, calculated using the average unadjusted closing price for the quarter. The fund’s quarter-end holding was 1,022,149 shares, with a reported value of $20.37 million.
Kestra Medical Technologies, Ltd. is a healthcare technology company specializing in advanced wearable devices and digital platforms for cardiac patient management. The company leverages intelligent, connected solutions to support both patients and providers, aiming to enhance clinical outcomes in cardiovascular disease. With a focus on innovation and integration, Kestra develops next-generation cardiac monitoring and intervention solutions.
NASDAQ: KMTS
KMTS Trading
-3.13% G/L:
$19.685 Last:
90,140 Volume:
$20.45 Open:
